According to the results, patients with high CCNE1 expression had a poorer prognosis than those with low expression in the ovarian cancer, breast cancer, gastric cancer, lung cancer, and liver cancer cohorts (Figure S2B). This evidence concerns the gene CCNE1 and gastric cancer.